TCL Archive Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial October 26, 2012
TCL Archive In Brief: NCAB Dec. Meeting Includes Biologics Symposium; Epidemiology Center Grant Program Disapproved November 29, 1985